Lin Pharmaceuticals is categorized under Noncommercial Research Organizations in San Francisco, CA and active since 2009.
Lin Pharmaceuticals was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Laura Kapitzky at the company’s single location by writing to 685 Mcallister St Apartment 206, San Francisco, California CA 94102 or by phoning (415) 476-3068. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Lin Pharmaceuticals |
| Contact Person: | Laura Kapitzky |
| Address: | 685 Mcallister St Apartment 206, San Francisco, California 94102 |
| Phone Number: | (415) 476-3068 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Research Organizations |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Lin Pharmaceuticals was started in 2009 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Laura Kapitzky for inquiries that concern Lin Pharmaceuticals by calling the company number (415) 476-3068, as your correspondence is most welcome. Additionally, the physical location of the single location of Lin Pharmaceuticals can be found at the coordinates 37.779556,-122.42334 as well as the street address 685 Mcallister St Apartment 206 in San Francisco, California 94102.
For its online presence, you may visit Lin Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.